Medicare Enrolled
Dr. Ajaz Khan, M.D.
Family Medicine · Mesquite, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Khan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khan?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Khan
Dr. Ajaz Khan is a family medicine specialist in Mesquite, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Khan performed 5,035 Medicare services across 1,754 unique beneficiaries.
Between the years covered by Open Payments, Dr. Khan received a total of $1,250 from 23 pharmaceutical and/or device companies across 58 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Khan is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 4% volume in TX
$1,250 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,035
Medicare services
Top 4% in TX for family medicine
1,754
Unique beneficiaries
$42
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~265 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
729 | $37 | $106 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
710 | $76 | $141 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
512 | $31 | $115 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
458 | $38 | $101 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
448 | $52 | $110 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
410 | $39 | $115 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
381 | $48 | $119 |
| Remote physiological data monitoring, 30 days Collection and interpretation of physical parameters transmitted by the patient or caregiver over a 30-day period, requiring at least 30 minutes of professional time. |
376 | $42 | $110 |
| Annual depression screening | 143 | $18 | $48 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
136 | $2 | $10 |
| Arterial injection of drug or substance A procedure where a medication or other substance is injected directly into an artery. |
80 | $14 | $99 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
57 | $10 | $47 |
| COVID-19 immunoassay detection test A laboratory test that uses an immunoassay method to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) through direct visual observation. |
56 | $41 | $100 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
46 | $1 | $52 |
| Psychotherapy and evaluation, 30 minutes A combined session involving psychotherapy and an evaluation and management visit lasting 30 minutes. |
41 | $44 | $105 |
| Influenza virus detection test A laboratory test that uses an immunoassay technique to detect the presence of the influenza virus through direct visual observation. |
38 | $16 | $75 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
38 | $28 | $72 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
38 | $0 | $180 |
| Strep A rapid test A rapid test to detect Group A Streptococcus bacteria using an immunoassay method with direct visual observation. |
37 | $16 | $125 |
| Ultrasound of arm and leg arteries A non-invasive imaging test that uses sound waves to examine the blood vessels in the arms and legs. It evaluates blood flow and checks for blockages or other vascular issues. |
37 | $101 | $194 |
| Autonomic nervous system function test This test evaluates how well the sympathetic nervous system is functioning. It assesses the automatic control of bodily processes such as heart rate and blood pressure. |
37 | $92 | $212 |
| Autonomic nervous system testing with tilt This test evaluates the function of the sympathetic and parasympathetic nervous systems. It involves monitoring the patient for at least five minutes while they are tilted. |
37 | $105 | $217 |
| Triamcinolone acetonide injection, 1 mg An injection of triamcinolone acetonide, a corticosteroid medication, administered in a 1 mg dose without preservatives. |
36 | $3 | $27 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
30 | $9 | $46 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
26 | $8 | $18 |
| Vaccine administration The process of giving a vaccine to a patient. This code covers the administration service only and does not include the cost of the vaccine itself. |
19 | $14 | $54 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 19 | $20 | $62 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
17 | $126 | $171 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
16 | $14 | $50 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
14 | $7 | $53 |
| Influenza virus nucleic acid detection test A laboratory test that uses nucleic acid technology to detect multiple types of influenza virus. |
13 | $94 | $195 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$1,250
Total received (2020-2024)
Avg $250/year across 5 years
Top 34% in TX for family medicine
23
Companies
58
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,250 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$540
2023
$408
2022
$203
2021
$77
2020
$22
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$243
GlaxoSmithKline, LLC.
$149
Abbott Laboratories
$149
Takeda Pharmaceuticals U.S.A., Inc.
$120
Novo Nordisk Inc
$82
Lilly USA, LLC
$65
ABBVIE INC.
$56
SHIELD THERAPEUTICS INC
$48
Amgen Inc.
$36
Medtronic, Inc.
$34
Astellas Pharma US Inc
$31
Bayer Healthcare Pharmaceuticals Inc.
$25
Shield Therapeutics Inc
$25
Merck Sharp & Dohme LLC
$24
PFIZER INC.
$23
Genentech USA, Inc.
$22
Bayer HealthCare Pharmaceuticals Inc.
$21
Scilex Pharmaceuticals Inc.
$20
Exact Sciences Corporation
$19
Boehringer Ingelheim Pharmaceuticals, Inc.
$16
IDORSIA PHARMACEUTICALS US INC
$16
Novartis Pharmaceuticals Corporation
$14
AbbVie Inc.
$11
Top 3 companies account for 43.3% of total payments
Associated products mentioned in payments ›
ACCRUFER · AREXVY · ASSURITY · BREZTRI · Cologuard Collection Kit · EMGALITY · ENTRESTO · FARXIGA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · INTELLIS ADAPTIVESTIM · JARDIANCE · Kerendia · MOUNJARO · Otezla · Ozempic · PAXLOVID · Proclaim IPG · QULIPTA · QUVIVIQ · Rybelsus · TRELEGY ELLIPTA · UBRELVY · VENASEAL · VERQUVO · VPRIV · VRAYLAR · Veozah · Xofluza
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $25 per 100 Medicare services performed
Geographic Context
Family medicine physicians within 10 mi
1,289
Per 100K population
49.5
County median income
$74,149
Nearest hospital
DALLAS REGIONAL MEDICAL CENTER
2.9 mi
2.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Khan is a clinical cardiology specialist, with above-average Medicare volume (top 4% in TX), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Khan experienced with chronic care management, additional 20 min/month?
Based on Medicare claims data, Dr. Khan performed 729 chronic care management, additional 20 min/month services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Khan receive payments from pharmaceutical companies?
Yes. Dr. Khan received a total of $1,250 from 23 companies across 58 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khan's costs compare to other family medicine physicians in Mesquite?
Dr. Khan's average Medicare payment per service is $42. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Mesquite
Browse family medicine physicians in Mesquite ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in TX
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in TX
Which TX family medicine physicians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology